Cargando…
Miltefosine and Antimonial Drug Susceptibility of Leishmania Viannia Species and Populations in Regions of High Transmission in Colombia
BACKGROUND: Pentavalent antimonials have been the first line treatment for dermal leishmaniasis in Colombia for over 30 years. Miltefosine is administered as second line treatment since 2005. The susceptibility of circulating populations of Leishmania to these drugs is unknown despite clinical evide...
Autores principales: | Fernández, Olga Lucía, Diaz-Toro, Yira, Ovalle, Clemencia, Valderrama, Liliana, Muvdi, Sandra, Rodríguez, Isabel, Gomez, María Adelaida, Saravia, Nancy Gore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031164/ https://www.ncbi.nlm.nih.gov/pubmed/24853871 http://dx.doi.org/10.1371/journal.pntd.0002871 |
Ejemplares similares
-
Resistance of Leishmania (Viannia) Panamensis to Meglumine Antimoniate or Miltefosine Modulates Neutrophil Effector Functions
por: Regli, Ivo B., et al.
Publicado: (2018) -
Correction: Miltefosine and Antimonial Drug Susceptibility of Leishmania Viannia Species and Populations in Regions of High Transmission in Colombia
Publicado: (2014) -
Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia)
por: Gómez, María Adelaida, et al.
Publicado: (2020) -
Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
por: Vincent, Isabel M., et al.
Publicado: (2015) -
Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia
por: Franco-Muñoz, Carlos, et al.
Publicado: (2018)